Selected research
Industry Research
Custom Recombinant Protein Production Service Industry Research Report 2026
Market perspective
The global Custom Recombinant Protein Production Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Custom Recombinant Protein Production Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Custom Recombinant Protein Production Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Custom Recombinant Protein Production Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Custom Recombinant Protein Production Service include VectorBuilder, Proteos, Creative Biolabs, Charles River, InVivo BioTech Services GmbH, eEnzyme, BiologicsCorp, Biomatik and RayBiotech, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Custom Recombinant Protein Production Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Custom Recombinant Protein Production Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Custom Recombinant Protein Production Service Market by Company
VectorBuilder
Proteos
Creative Biolabs
Charles River
InVivo BioTech Services GmbH
eEnzyme
BiologicsCorp
Biomatik
RayBiotech
R&D Systems
OriGene Technologies
Applied Biological Materials Inc. (abm)
Creative BioMart
Levprot Bioscience
Jubilant Biosys
Kinexus Bioinformatics
NorthX Biologics
Leinco Technologies
GenScript
KACTUS
G &P Biosciences
Boster Bio
Eurofins Discovery
Custom Recombinant Protein Production Service Segment by Type
Mammalian Cell Based
Bacteria Based
Insect Cell Based
Others
Custom Recombinant Protein Production Service Segment by Application
Basic Scientific Research
Monoclonal Antibody Drug Development
Therapeutic Protein Production
Mrna Vaccine Research
Others
Custom Recombinant Protein Production Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Recombinant Protein Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Recombinant Protein Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Recombinant Protein Production Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Custom Recombinant Protein Production Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mammalian Cell Based
- Bacteria Based
- Insect Cell Based
- Others
Applications
- Basic Scientific Research
- Monoclonal Antibody Drug Development
- Therapeutic Protein Production
- Mrna Vaccine Research
- Others
Companies covered
- VectorBuilder
- Proteos
- Creative Biolabs
- Charles River
- InVivo BioTech Services GmbH
- eEnzyme
- BiologicsCorp
- Biomatik
- RayBiotech
- R&D Systems
- OriGene Technologies
- Applied Biological Materials Inc. (abm)
- Creative BioMart
- Levprot Bioscience
- Jubilant Biosys
- Kinexus Bioinformatics
- NorthX Biologics
- Leinco Technologies
- GenScript
- KACTUS
- G &P Biosciences
- Boster Bio
- Eurofins Discovery
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Custom Recombinant Protein Production Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Mammalian Cell Based
- 2.2.3 Bacteria Based
- 2.2.4 Insect Cell Based
- 2.2.5 Others
- 2.3 Custom Recombinant Protein Production Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Basic Scientific Research
- 2.3.3 Monoclonal Antibody Drug Development
- 2.3.4 Therapeutic Protein Production
- 2.3.5 Mrna Vaccine Research
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Custom Recombinant Protein Production Service Breakdown Data by Type
- 3.1 Global Custom Recombinant Protein Production Service Historic Market Size by Type (2021-2026)
- 3.2 Global Custom Recombinant Protein Production Service Forecasted Market Size by Type (2027-2032)
4 Custom Recombinant Protein Production Service Breakdown Data by Application
- 4.1 Global Custom Recombinant Protein Production Service Historic Market Size by Application (2021-2026)
- 4.2 Global Custom Recombinant Protein Production Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Custom Recombinant Protein Production Service Market Perspective (2021-2032)
- 5.2 Global Custom Recombinant Protein Production Service Growth Trends by Region
- 5.2.1 Global Custom Recombinant Protein Production Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Custom Recombinant Protein Production Service Historic Market Size by Region (2021-2026)
- 5.2.3 Custom Recombinant Protein Production Service Forecasted Market Size by Region (2027-2032)
- 5.3 Custom Recombinant Protein Production Service Market Dynamics
- 5.3.1 Custom Recombinant Protein Production Service Industry Trends
- 5.3.2 Custom Recombinant Protein Production Service Market Drivers
- 5.3.3 Custom Recombinant Protein Production Service Market Challenges
- 5.3.4 Custom Recombinant Protein Production Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Custom Recombinant Protein Production Service Players by Revenue
- 6.1.1 Global Top Custom Recombinant Protein Production Service Players by Revenue (2021-2026)
- 6.1.2 Global Custom Recombinant Protein Production Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Custom Recombinant Protein Production Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Custom Recombinant Protein Production Service Head Office and Area Served
- 6.4 Global Custom Recombinant Protein Production Service Players, Product Type & Application
- 6.5 Global Custom Recombinant Protein Production Service Manufacturers Established Date
- 6.6 Global Custom Recombinant Protein Production Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Custom Recombinant Protein Production Service Market Size (2021-2032)
- 7.2 North America Custom Recombinant Protein Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Custom Recombinant Protein Production Service Market Size by Country (2021-2026)
- 7.4 North America Custom Recombinant Protein Production Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Custom Recombinant Protein Production Service Market Size (2021-2032)
- 8.2 Europe Custom Recombinant Protein Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Custom Recombinant Protein Production Service Market Size by Country (2021-2026)
- 8.4 Europe Custom Recombinant Protein Production Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Custom Recombinant Protein Production Service Market Size (2021-2032)
- 9.2 Asia-Pacific Custom Recombinant Protein Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Custom Recombinant Protein Production Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Custom Recombinant Protein Production Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Custom Recombinant Protein Production Service Market Size (2021-2032)
- 10.2 South America Custom Recombinant Protein Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Custom Recombinant Protein Production Service Market Size by Country (2021-2026)
- 10.4 South America Custom Recombinant Protein Production Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Custom Recombinant Protein Production Service Market Size (2021-2032)
- 11.2 Middle East & Africa Custom Recombinant Protein Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Custom Recombinant Protein Production Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Custom Recombinant Protein Production Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 VectorBuilder
- 12.1.1 VectorBuilder Company Information
- 12.1.2 VectorBuilder Business Overview
- 12.1.3 VectorBuilder Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.1.4 VectorBuilder Custom Recombinant Protein Production Service Product Portfolio
- 12.1.5 VectorBuilder Recent Developments
- 12.2 Proteos
- 12.2.1 Proteos Company Information
- 12.2.2 Proteos Business Overview
- 12.2.3 Proteos Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.2.4 Proteos Custom Recombinant Protein Production Service Product Portfolio
- 12.2.5 Proteos Recent Developments
- 12.3 Creative Biolabs
- 12.3.1 Creative Biolabs Company Information
- 12.3.2 Creative Biolabs Business Overview
- 12.3.3 Creative Biolabs Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.3.4 Creative Biolabs Custom Recombinant Protein Production Service Product Portfolio
- 12.3.5 Creative Biolabs Recent Developments
- 12.4 Charles River
- 12.4.1 Charles River Company Information
- 12.4.2 Charles River Business Overview
- 12.4.3 Charles River Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.4.4 Charles River Custom Recombinant Protein Production Service Product Portfolio
- 12.4.5 Charles River Recent Developments
- 12.5 InVivo BioTech Services GmbH
- 12.5.1 InVivo BioTech Services GmbH Company Information
- 12.5.2 InVivo BioTech Services GmbH Business Overview
- 12.5.3 InVivo BioTech Services GmbH Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.5.4 InVivo BioTech Services GmbH Custom Recombinant Protein Production Service Product Portfolio
- 12.5.5 InVivo BioTech Services GmbH Recent Developments
- 12.6 eEnzyme
- 12.6.1 eEnzyme Company Information
- 12.6.2 eEnzyme Business Overview
- 12.6.3 eEnzyme Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.6.4 eEnzyme Custom Recombinant Protein Production Service Product Portfolio
- 12.6.5 eEnzyme Recent Developments
- 12.7 BiologicsCorp
- 12.7.1 BiologicsCorp Company Information
- 12.7.2 BiologicsCorp Business Overview
- 12.7.3 BiologicsCorp Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.7.4 BiologicsCorp Custom Recombinant Protein Production Service Product Portfolio
- 12.7.5 BiologicsCorp Recent Developments
- 12.8 Biomatik
- 12.8.1 Biomatik Company Information
- 12.8.2 Biomatik Business Overview
- 12.8.3 Biomatik Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.8.4 Biomatik Custom Recombinant Protein Production Service Product Portfolio
- 12.8.5 Biomatik Recent Developments
- 12.9 RayBiotech
- 12.9.1 RayBiotech Company Information
- 12.9.2 RayBiotech Business Overview
- 12.9.3 RayBiotech Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.9.4 RayBiotech Custom Recombinant Protein Production Service Product Portfolio
- 12.9.5 RayBiotech Recent Developments
- 12.10 R&D Systems
- 12.10.1 R&D Systems Company Information
- 12.10.2 R&D Systems Business Overview
- 12.10.3 R&D Systems Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.10.4 R&D Systems Custom Recombinant Protein Production Service Product Portfolio
- 12.10.5 R&D Systems Recent Developments
- 12.11 OriGene Technologies
- 12.11.1 OriGene Technologies Company Information
- 12.11.2 OriGene Technologies Business Overview
- 12.11.3 OriGene Technologies Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.11.4 OriGene Technologies Custom Recombinant Protein Production Service Product Portfolio
- 12.11.5 OriGene Technologies Recent Developments
- 12.12 Applied Biological Materials Inc. (abm)
- 12.12.1 Applied Biological Materials Inc. (abm) Company Information
- 12.12.2 Applied Biological Materials Inc. (abm) Business Overview
- 12.12.3 Applied Biological Materials Inc. (abm) Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.12.4 Applied Biological Materials Inc. (abm) Custom Recombinant Protein Production Service Product Portfolio
- 12.12.5 Applied Biological Materials Inc. (abm) Recent Developments
- 12.13 Creative BioMart
- 12.13.1 Creative BioMart Company Information
- 12.13.2 Creative BioMart Business Overview
- 12.13.3 Creative BioMart Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.13.4 Creative BioMart Custom Recombinant Protein Production Service Product Portfolio
- 12.13.5 Creative BioMart Recent Developments
- 12.14 Levprot Bioscience
- 12.14.1 Levprot Bioscience Company Information
- 12.14.2 Levprot Bioscience Business Overview
- 12.14.3 Levprot Bioscience Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.14.4 Levprot Bioscience Custom Recombinant Protein Production Service Product Portfolio
- 12.14.5 Levprot Bioscience Recent Developments
- 12.15 Jubilant Biosys
- 12.15.1 Jubilant Biosys Company Information
- 12.15.2 Jubilant Biosys Business Overview
- 12.15.3 Jubilant Biosys Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.15.4 Jubilant Biosys Custom Recombinant Protein Production Service Product Portfolio
- 12.15.5 Jubilant Biosys Recent Developments
- 12.16 Kinexus Bioinformatics
- 12.16.1 Kinexus Bioinformatics Company Information
- 12.16.2 Kinexus Bioinformatics Business Overview
- 12.16.3 Kinexus Bioinformatics Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.16.4 Kinexus Bioinformatics Custom Recombinant Protein Production Service Product Portfolio
- 12.16.5 Kinexus Bioinformatics Recent Developments
- 12.17 NorthX Biologics
- 12.17.1 NorthX Biologics Company Information
- 12.17.2 NorthX Biologics Business Overview
- 12.17.3 NorthX Biologics Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.17.4 NorthX Biologics Custom Recombinant Protein Production Service Product Portfolio
- 12.17.5 NorthX Biologics Recent Developments
- 12.18 Leinco Technologies
- 12.18.1 Leinco Technologies Company Information
- 12.18.2 Leinco Technologies Business Overview
- 12.18.3 Leinco Technologies Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.18.4 Leinco Technologies Custom Recombinant Protein Production Service Product Portfolio
- 12.18.5 Leinco Technologies Recent Developments
- 12.19 GenScript
- 12.19.1 GenScript Company Information
- 12.19.2 GenScript Business Overview
- 12.19.3 GenScript Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.19.4 GenScript Custom Recombinant Protein Production Service Product Portfolio
- 12.19.5 GenScript Recent Developments
- 12.20 KACTUS
- 12.20.1 KACTUS Company Information
- 12.20.2 KACTUS Business Overview
- 12.20.3 KACTUS Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.20.4 KACTUS Custom Recombinant Protein Production Service Product Portfolio
- 12.20.5 KACTUS Recent Developments
- 12.21 G &P Biosciences
- 12.21.1 G &P Biosciences Company Information
- 12.21.2 G &P Biosciences Business Overview
- 12.21.3 G &P Biosciences Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.21.4 G &P Biosciences Custom Recombinant Protein Production Service Product Portfolio
- 12.21.5 G &P Biosciences Recent Developments
- 12.22 Boster Bio
- 12.22.1 Boster Bio Company Information
- 12.22.2 Boster Bio Business Overview
- 12.22.3 Boster Bio Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.22.4 Boster Bio Custom Recombinant Protein Production Service Product Portfolio
- 12.22.5 Boster Bio Recent Developments
- 12.23 Eurofins Discovery
- 12.23.1 Eurofins Discovery Company Information
- 12.23.2 Eurofins Discovery Business Overview
- 12.23.3 Eurofins Discovery Revenue in Custom Recombinant Protein Production Service Business (2021-2026)
- 12.23.4 Eurofins Discovery Custom Recombinant Protein Production Service Product Portfolio
- 12.23.5 Eurofins Discovery Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst